Filing Details
- Accession Number:
- 0001209191-16-089349
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-01-05 18:39:46
- Reporting Period:
- 2016-01-04
- Filing Date:
- 2016-01-05
- Accepted Time:
- 2016-01-05 18:39:46
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1604821 | Natera Inc. | NTRA | Services-Medical Laboratories (8071) | 010894487 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1646382 | Matthew Rabinowitz | C/O Natera, Inc. 201 Industrial Road, Suite 410 San Carlos CA 94070 | Ceo, President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-01-04 | 52,113 | $10.39 | 2,765,347 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-01-05 | 2,570 | $10.06 | 2,762,777 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The reported price in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $10.1050 to $10.7600 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- The reported price in Column 4 is a weighted average. These shares were sold in multiple transactions at prices ranging from $10.0000 to $10.25000 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.